Gsa Capital Partners LLP Ironwood Pharmaceuticals Inc Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 351,193 shares of IRWD stock, worth $1.24 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

351,193

Previous 119,106 194.86%

Holding current value

$1.24 Million

Previous $777,000 86.23%

% of portfolio

0.11%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$3.93 - $7.04 $912,101 - $1.63 Million	232,087 Added 194.86%	351,193 $1.45 Million
Q2 2024 Aug 15, 2024	SELL	$5.58 - $8.61 $318,428 - $491,338	-57,066 Reduced 32.39%	119,106 $777,000
Q1 2024 May 03, 2024	BUY	$8.32 - $15.45 $1.47 Million - $2.72 Million	176,172 New	176,172 $1.53 Million
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $400,485 - $459,963	-39,652 Reduced 38.4%	63,606 $676,000
Q1 2023 May 12, 2023	BUY	$10.37 - $12.56 $438,744 - $531,401	42,309 Added 69.42%	103,258 $1.09 Million
Q4 2022 Feb 13, 2023	BUY	$9.9 - $12.43 $128,769 - $161,677	13,007 Added 27.13%	60,949 $755,000
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $379,651 - $463,519	37,441 Added 356.55%	47,942 $497,000
Q2 2022 Aug 09, 2022	SELL	$11.05 - $12.72 $789,854 - $909,225	-71,480 Reduced 87.19%	10,501 $121,000
Q1 2022 May 11, 2022	BUY	$10.61 - $12.88 $869,818 - $1.06 Million	81,981 New	81,981 $1.03 Million
Q4 2020 Feb 03, 2021	SELL	$9.05 - $12.2 $861,243 - $1.16 Million	-95,165 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$8.99 - $10.74 $855,533 - $1.02 Million	95,165 New	95,165 $856,000
Q1 2020 May 12, 2020	SELL	$8.58 - $14.01 $735,426 - $1.2 Million	-85,714 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$8.22 - $14.0 $13,373 - $22,778	1,627 Added 1.93%	85,714 $1.14 Million
Q3 2019 Nov 12, 2019	BUY	$8.59 - $10.96 $722,307 - $921,593	84,087 New	84,087 $722,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Ironwood Pharmaceuticals Inc Transaction History